Now that oncology patients are surviving longer, survival rate alone is insufficient for novel therapy evaluations. Patient-reported outcomes (PROs) offer an improved option for research outcomes. Check out this comprehensive and actionable guide for integrating PROs into your oncology trial.
Key Takeaways:
- Regulatory Shifts: How PROs are shaping regulatory agency directives
- Trial Harmonization: The role of PROs in streamlining global clinical trials
- Economic Impact: PROs’ influence on payor reimbursement strategies
- Patient-Centered Approach: Prioritizing the patient’s perspective for better outcomes
- Best Practices: Strategies for effective PRO integration in clinical trials
Authors:
Michael Murphy, MD, PhD
Chief Medical and Scientific Officer
Matthew Confeld, PharmD, PhD
Assistant Director, Clinical Research Methodology
